Characteristics of the combination paclitaxel plus doxorubicin in breast cancer cell lines analyzed with the ATP-Cell Viability Assay
- 1 January 1993
- journal article
- Published by Springer Nature in Breast Cancer Research and Treatment
- Vol. 28 (1) , 21-27
- https://doi.org/10.1007/bf00666352
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- The use of ATP bioluminescence assay and flow cytometry in predicting radiosensitivity of uterine cancer cell lines: Correlation of radiotoxicity and cell cycle kineticsGynecologic Oncology, 1992
- Overview of new treatments for breast cancerBreast Cancer Research and Treatment, 1992
- Rationale of Combining Radiation and Interferon for the Treatment of Cervical CancerOncology, 1992
- Comparative evaluation of single and combination chemotherapy in uterine cancer cell linesGynecologic Oncology, 1991
- The effects of provera on chemotherapy of uterine cancer cell linesGynecologic Oncology, 1991
- A novel in vitro chemosensitivity test using materials collected by endoscopic biopsyAnti-Cancer Drugs, 1991
- Comparative chemosensitivity profiles in four human ovarian carcinoma cell lines measuring ATP bioluminescenceGynecologic Oncology, 1990
- Application of an ATP-bioluminescence assay in human tumor chemosensitivity testingGynecologic Oncology, 1988
- Comparison of the chemosensitivity of human neoplastic tissues between succinate dehydrogenase inhibition test and ATP assayClinica Chimica Acta; International Journal of Clinical Chemistry, 1987
- The Use of Bioluminescence to Evaluate the Influence of Chemotherapeutic Drugs on ATP-Levels of Malignant Cell Linescclm, 1986